Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette’s syndrome and obsessive–compulsive disorder
- 15 September 2000
- journal article
- Published by Elsevier in Brain Research
- Vol. 877 (1), 23-30
- https://doi.org/10.1016/s0006-8993(00)02646-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Behavioral effects of cocaine on a transgenic mouse model of cortical–limbic compulsionBrain Research, 1999
- OCD-Like Behaviors Caused by a Neuropotentiating Transgene Targeted to Cortical and Limbic D1+ NeuronsJournal of Neuroscience, 1999
- Differential response of cortical–limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonistsEuropean Journal of Pharmacology, 1999
- Detecting Subtle Differences in Behavior Using Waveform Display AnalysisPhysiology & Behavior, 1998
- Functional MRI and the Study of OCD: From Symptom Provocation to Cognitive-Behavioral Probes of Cortico-Striatal Systems and the AmygdalaNeuroImage, 1996
- Functional Magnetic Resonance Imaging of Symptom Provocation in Obsessive-compulsive DisorderArchives of General Psychiatry, 1996
- Measurement of an Explosive Behavior in the Mouse, Induced by MK-801, a PCP AnalogueClinical Neuropharmacology, 1993
- Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgeneNature, 1991
- Obsessions and compulsions in Gilles de la Tourette's syndromeNeurology, 1986
- An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-Amphetamine and apomorphinePsychopharmacology, 1980